Research Methods

Bioavailability

The fraction of an administered dose that reaches systemic circulation in an active form. Varies substantially by route of administration for cannabinoids.

In Depth

Cannabinoid bioavailability varies dramatically by route: inhalation (11–45%), oral (6–20% due to first-pass metabolism and lipophilicity), sublingual (13–19%), and transdermal (<1% without permeation enhancers). The high variability in oral bioavailability makes dose standardization challenging. Food, particularly high-fat meals, significantly increases oral CBD and THC absorption. Inhalation provides the fastest onset (minutes) but shortest duration; oral provides slowest onset (30–120 min) but longest duration.

Related Terms

PharmacokineticsFirst-Pass MetabolismRoute of Administration